2/2 Collaborative Union for Cancer Research, Education, and Disparities (CURED)

2/2 癌症研究、教育和差异合作联盟 (CURED)

• 批准号: 10762045
• 负责人: Veronica B Ajewole
• 金额: $ 28.56万
• 依托单位: TEXAS SOUTHERN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-21 至 2027-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10762045
• 关键词: Address; Advisory Committees; African American; Area; Cancer Center; Career Choice; Collaborations; Communities; Community Health Education; Community Outreach; Comprehensive Cancer Center; Cost Allocation; Data; Degree program; Development; Disparity; Education; Education and Outreach; Educational Curriculum; Effectiveness; Emerging Technologies; Ensure; Environment; Evaluation; Exposure to; Facilities and Administrative Costs; Faculty; Fostering; Funding; Funding Agency; Goals; Health Disparities Research; Historically Black Colleges and Universities; Infrastructure; Institution; Joints; Lead; Leadership; Malignant Neoplasms; Medical center; Medicine; Mentors; Minority Health Research; National Cancer Institute; Pilot Projects; Prevention; Process; Program Development; Research; Research Peer Review; Research Personnel; Resources; Schools; Science; Students; Texas; Training; Training Support; Underrepresented Students; Underserved Population; United States National Institutes of Health; Universities; anticancer research; cancer education; cancer health disparity; career; career development; college; cost; design; education research; empowerment; ethnic diversity; experience; graduate student; higher education; improved; innovation; member; outreach; outreach program; programs; research and development; summer student; undergraduate student; university student

CURED Overall Abstract Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 application to build a collaborative partnership in cancer research, education, and outreach. DLDCCC is a National Cancer Institute (NCI) designated cancer center. TSU is one of the nation’s largest Historically Black Colleges and Universities (HBCU) serving underserved populations and underrepresented students (ISUPSs). BCM and TSU have had several successful collaborations. This relationship was strengthened recently through TSU’s U54 “Center for Biomedical and Minority Health Research”, where BCM faculty have partnered closely on collaborative cancer disparities community education and outreach. This P20 program provides an excellent opportunity for TSU and BCM to expand collaborations. We propose a BCM-TSU P20 program “Collaborative Union for Cancer Research, Education and Disparities” (CURED) that will foster strong collaborations utilizing our complementary strengths. Overall objectives are to create a shared infrastructure that will provide an optimal environment for cancer research, education, community outreach, and career development and diversify the biomedical workforce. CURED was established under the direction of senior leadership at each institution, reflected in the significant institutional support for this partnership. BCM has committed $160,000/year for four years in cost matching funds, $ 50,000 for Pilot project 2 for one year, and committed funds to support the training of TSU summer students in the Cancer Research Education Program. TSU has committed to return the Indirect Cost allocation amounting to $98,000 each year. All TSU investigators are members of the DLDCCC. Leaders of each institution are thus committed to empower the P20 partnership to address cancer health disparities among URM and underserved populations in Houston. Our goals are to (1) establish a collaborative alliance between BCM and TSU for cancer research, education, and community outreach. We will (a) establish CURED offices in both institutions that will provide coordination for relevant activities, evaluate progress of current projects, and ensure a pipeline of innovative pilot projects; (b) centralize institutional resources for faculty/trainee research needs (c) lead a cancer research and career development program for TSU students that includes mentored cancer research, an educational curriculum, hands-on training in emerging technologies, and professional development; (d) build a BCM/TSU comprehensive outreach program to address cancer disparities at the bench, bedside, and within the community; and (2) to support a pipeline of collaborative innovative cancer research pilot projects. Overall Impact: We are certain that the proposed CURED will enhance cancer research education capacity at TSU, promote a diverse research workforce, and improve BCM/DLDCCC’s effectiveness in developing and sustaining research programs focused on cancer health disparities. We will develop sustainable research capacity leading to independent and collaborative applications to the NIH/other Federal/Non-federal agencies.

CURED 整体摘要 德克萨斯州贝勒医学院 (BCM) 的 Dan L Duncan 综合癌症中心 (DLDCCC) 南方大学 (TSU) 联合提交 P20 申请，建立癌症领域的合作伙伴关系 DLDCCC 是美国国家癌症研究所 (NCI) 指定的癌症中心。 是美国最大的历史黑人学院和大学 (HBCU) 之一，为服务不足的群体提供服务 人口和代表性不足的学生 (ISUPS) 已经取得了一些成功。 这种合作最近通过 TSU 的 U54“生物医学和中心”得到了加强。 少数族裔健康研究”，BCM 教师在癌症差异方面密切合作 该 P20 计划为 TSU 和 BCM 提供了绝佳的机会。 我们提出了 BCM-TSU P20 计划“癌症研究合作联盟”。 教育与差异”（CURED），这将利用我们的互补优势促进强有力的合作。 总体目标是创建一个共享基础设施，为癌症提供最佳环境 研究、教育、社区外展和职业发展，并使生物医学劳动力多样化。 CURED 是在各机构高层领导的指导下成立的，这体现在 BCM 已承诺在四年内每年提供 160,000 美元的机构支持，作为成本匹配资金， 试点项目 2 为期一年 50,000 美元，并承诺资金支持 TSU 暑期学生的培训 TSU 已承诺退还间接成本分配金额。 每年 98,000 美元，所有 TSU 研究人员都是 DLDCCC 的成员。 致力于增强 P20 伙伴关系的能力，以解决 URM 和服务不足的地区之间的癌症健康差异 我们的目标是 (1) 在 BCM 和 TSU 之间建立癌症合作联盟。 我们将 (a) 在两个机构中设立 CURED 办公室。 协调相关活动，评估当前项目的进展，并确保管道 创新试点项目；(b) 集中机构资源以满足教师/实习生的研究需求；(c) 引领癌症 为 TSU 学生提供的研究和职业发展计划，包括指导癌症研究、 (d) 建立一个 BCM/TSU 综合外展计划旨在解决实验室、床边和内部的癌症差异 社区；(2) 支持一系列合作创新癌症研究试点项目。 总体影响：我们确信拟议的 CURED 将增强癌症研究教育能力 TSU，促进多元化的研究队伍，并提高 BCM/DLDCCC 在开发和 持续关注癌症健康差异的研究计划 我们将开展可持续研究。 向 NIH/其他联邦/非联邦机构独立和协作申请的能力。